Hemolysis associated with prosthetic heart valves: A review

Cardiology in Review

Volumn 17, Issue 3, 2009, Pages 121-124

  Shapira, Yaron ^a   Vaturi, Mordehay ^b   Sagie, Alex ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Hemolysis; Paravalvular leak; Percutaneous closure; Prosthetic heart valve

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHROMIUM 51; ERYTHROPOIETIN; FOLIC ACID; IRON; PENTOXIFYLLINE; PLACEBO;

ANEMIA; BLOOD SMEAR; BLOOD TRANSFUSION; DISEASE SEVERITY; ERYTHROCYTE LIFESPAN; FLUOROSCOPY; FOLIC ACID DEFICIENCY; GOLD STANDARD; HEART VALVE PROSTHESIS; HEMOLYSIS; HUMAN; POSTOPERATIVE COMPLICATION; PREVENTION AND CONTROL; REVIEW; SURGICAL RISK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL VALVULOPLASTY; VALVULAR HEART DISEASE; VITAMIN SUPPLEMENTATION; CARDIOVASCULAR SURGERY; HEART VALVE; HEMOLYTIC ANEMIA; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANEMIA, HEMOLYTIC; CARDIOVASCULAR SURGICAL PROCEDURES; HEART VALVE PROSTHESIS; HEART VALVES; HEMOLYSIS; HUMANS; TREATMENT OUTCOME;

EID: 67549085143     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31819f1a83     Document Type: Review

References (54)

1. Edmunds LH Jr, Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg. 1996;112:708 -711.
2. Rose JC, Hufnagel CA, Fries ED, et al. The hemodynamic alterations produced by plastic valvular prosthesis for severe aortic insufficiency in man. J Clin Invest. 1954;33:891-900.
3. Marsh GW, Lewis SM. Cardiac haemolytic anaemia. Semin Hematol. 1969; 6:133-149.
4. Kloster FE. Diagnosis and management of complications of prosthetic heart valves. Am J Cardiol. 1975;35:872- 885.
5. Iguro Y, Moriyama Y, Yamaoka A, et al. Clinical experience of 473 patients with the omnicarbon prosthetic heart valve. J Heart Valve Dis. 1999;8:674-679.
6. Skoularigis J, Essop MR, Skudicky D, et al. Frequency and severity of intravascular hemolysis after left-sided cardiac valve replacement with Medtronic Hall and St. Jude Medical prostheses, and influence of prosthetic type, position, size, and number. Am J Cardiol. 1993;71:587-591.
7. Mecozzi G, Milano AD, De Carlo M, et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg. 2002;123:550 -556.
8. Mitlyng BL, Chandrashekhar Y, Furne JK, et al. Use of breath carbon monoxide to measure the influence of prosthetic heart valves on erythrocyte survival. Am J Cardiol. 2006;97:1374 -1376.
9. Conti VR, Nishimura A, Coughlin TR, et al. Indications for replacement of the Beall 103 and 104 disc valves. Ann Thorac Surg. 1986;42:315-320.
10. Murakami M, Tanaka H, Watanabe M, et al. Severe hemolysis due to cloth wear 23 years after aortic valve replacement on a Starr-Edwards ball valve model 2320. Cardiovasc Surg. 2002;10:284 -286.
11. Rallidis LS, Moyssakis IE, Ikonomidis I, et al. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J. 1999;138: 351-357.
12. Miller DL, Morris JJ, Schaff HV, et al. Reoperation for aortic valve periprosthetic leakage: identification of patients at risk and results of operation. J Heart Valve Dis. 1995;4:160 -165.
13. Jindani A, Neville EM, Venn G, et al. Paraprosthetic leak: a complication of cardiac valve replacement. J Cardiovasc Surg (Torino). 1991;32:503-508.
14. Schoen FJ. The first step to understanding valve failure: an overview of pathology. Eur J Cardiothorac Surg. 1992;6(suppl 1):S50 -S53.
15. Koch A, Cesnjevar R, Buheitel G, et al. Aortic root abscess complicated by fistulization and intracerebral hemorrhagic infarction. Pediatr Cardiol. 2003; 24:576 -580.
16. Alonso-Lej F. Straight suture plane to avoid periprosthetic leak in aortic valve replacement. Ann Thorac Surg. 1975;19:571-573.
17. Bortolotti U, Mazzucco A, Milano A, et al. Technical considerations in reoperation for porcine bioprosthetic valve failure. J Card Surg. 1988;3:459-466.
18. Laks H, Pearl JM, Barthel SW, et al. Aortic valve replacement using a continuous suture technique. J Card Surg. 1993;8:459-465.
19. Dhasmana JP, Blackstone EH, Kirklin JW, et al. Factors associated with periprosthetic leakage following primary mitral valve replacement: with special consideration of suture technique. Ann Thorac Surg. 1983;35:170-178.
20. Garcia MJ, Vandervoort P, Stewart WJ, et al. Mechanisms of hemolysis with mitral prosthetic regurgitation. Study using transesophageal echocardiography and fluid dynamic simulation. J Am Coll Cardiol. 1996;27:399-406.
21. Schwalm SA, Sugeng L, Ward RP, et al. Combination of acceleration and collision involving the left atrial appendage limbus as a mechanism of hemolytic anemia in the setting of periprosthetic mitral valve regurgitation. J Am Soc Echocardiogr. 2004;17:913-915.
22. Enzenauer RJ, Berenberg JL, Cassell PF Jr. Microangiopathic hemolytic anemia as the initial manifestation of porcine valve failure. South Med J. 1990;83:912-917.
23. Weesner KM, Rocchini AP, Rosenthal A, et al. Intravascular hemolysis associated with porcine mitral valve calcification in children. Am J Cardiol. 1981;47:1286 -1288.
24. Horstkotte D. Heart Valve Consultant. 1st ed. London: ICR Publishers; 1991.
25. Maraj R, Jacobs LE, Ioli A, et al. Evaluation of hemolysis in patients with prosthetic heart valves. Clin Cardiol. 1998;21:387-392.
26. Okita Y, Miki S, Kusuhara K, et al. Propranolol for intractable hemolysis after open heart operation. Ann Thorac Surg. 1991;52:1158 -1160.
27. Santinga JT, Flora JD, Rush JB, et al. The effect of propranolol on hemolysis in patients with an aortic prosthetic valve. Am Heart J. 1977;93:197-201.
28. Aoyagi S, Fukunaga S, Tayama E, et al. Benefits of a β-blocker for intractable hemolysis due to paraprosthetic leakage. Asian Cardiovasc Thorac Ann. 2007;15:441- 443.
29. Golbasi I, Turkay C, Timuragaoglu A, et al. The effect of pentoxifylline on haemolysis in patients with double cardiac prosthetic valves. Acta Cardiol. 2003;58:379 -383.
30. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268.
31. Pansini S, Ottino G, Forsennati PG, et al. Reoperations on heart valve prostheses: an analysis of operative risks and late results. Ann Thorac Surg. 1990;50:590 -596.
32. Cohn LH, Aranki SF, Rizzo RJ, et al. Decrease in operative risk of reoperative valve surgery. Ann Thorac Surg. 1993;56:15-20.
33. Jones JM, O'Kane H, Gladstone DJ, et al. Repeat heart valve surgery: risk factors for operative mortality. J Thorac Cardiovasc Surg. 2001;122:913-918.
34. Lytle BW, Cosgrove DM, Taylor PC, et al. Reoperations for valve surgery: perioperative mortality and determinants of risk for 1,000 patients, 1958-1984. Ann Thorac Surg. 1986;42:632- 643.
35. Akins CW, Buckley MJ, Daggett WM, et al. Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg. 1998;65:1545-1551.
36. Tyers GF, Jamieson WR, Munro AI, et al. Reoperation in biological and mechanical valve populations: fate of the reoperative patient. Ann Thorac Surg. 1995;60:S464 -S468.
37. Blackstone EH, Kirklin JW. Death and other time-related events after valve replacement. Circulation. 1985;72:753-767.
38. Hourihan M, Perry SB, Mandell VS, et al. Transcatheter umbrella closure of valvular and paravalvular leaks. J Am Coll Cardiol. 1992;20:1371-1377.
39. Hein R, Lang K, Wunderlich N, et al. Percutaneous closure of paravalvular leaks. J Interven Cardiol. 2006;19:S73-S77.
40. Pate GE, Thompson CR, Munt BI, et al. Techniques for percutaneous closure of prosthetic paravalvular leaks. Catheter Cardiovasc Interv. 2006;67:158-166.
41. Pate GE, Al Zubaidi A, Chandavimol M, et al. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv. 2006;68:528 -533.
42. Shapira Y, Hirsch R, Kornowski R, et al. Percutaneous closure of perivalvular leaks with Amplatzer occluders: feasibility, safety, and short-term results. J Heart Valve Dis. 2007;16:305-313.
43. Moore JD, Lashus AG, Prieto LR, et al. Transcatheter coil occlusion of perivalvular mitral leaks associated with severe hemolysis. Catheter Cardiovasc Interv. 2000;49:64-67.
44. Moscucci M, Deeb GM, Bach D, et al. Coil embolization of a periprosthetic mitral valve leak associated with severe hemolytic anemia. Circulation. 2001;104:E85-E86.
45. Eisenhauer AC, Piemonte TC, Watson PS. Closure of prosthetic paravalvular mitral regurgitation with the Gianturco-Grifka vascular occlusion device. Catheter Cardiovasc Interv. 2001;54:234 -238.
46. Hussain ST, Devagourou V, Sampath Kumar A. Management of mitral paravalvular leak: therapy or misadventure? J Thorac Cardiovasc Surg. 2003;126:879-880.
47. Biner S, Rafique AM, Kar S, et al. Live three-dimensional transesophageal echocardiography-guided transcatheter closure of a mitral paraprosthetic leak by Amplatzer occluder. J Am Soc Echocardiogr. 2008;21:1282.e7- e9.
48. Fischer GW, Adams DA. Real-time three-dimensional TEE-guided repair of a paravalvular leak after mitral valve replacement. Eur J Echocardiogr. 2008;9:868-869.
49. Kornowski R, Schwartz D, Jaffe A, et al. Erythropoietin therapy obviates the need for recurrent transfusions in a patient with severe hemolysis due to prosthetic valves. Chest. 1992;102:315-316.
50. Shapira Y, Bairey O, Vatury M, et al. Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia. Report of 3 cases and review of the literature. J Heart Valve Dis. 2001;10:431- 435.
51. Hirawat S, Lichtman SM, Allen SL Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment. Am J Hematol. 2001;66:224 -226.
52. Click RL, Abel MD, Schaff HV. Intraoperative transesophageal echocardiography: 5-year prospective review of impact on surgical management. Mayo Clin Proc. 2000;75:241-247.
53. Shapira Y, Mordehay M, Weisenberg DE, et al. Impact of intraoperative transesophageal echocardiography in patients undergoing valve replacement. Ann Thorac Surg. 2004;78:579 -583.
54. Feindel CM, Tufail Z, David TE, et al. Mitral valve surgery in patients with extensive calcification of the mitral annulus. J Thorac Cardiovasc Surg. 2003;126:777-782.